High dose rate brachytherapy of localized prostate cancer

European Urology

Volumn 41, Issue 4, 2002, Pages 420-426

  Deger, Serdar ^a   Boehmer, Dirk ^a   Türk, Ingolf ^a   Roigas, Jan ^a   Wernecke, Klaus Dieter ^a   Wiegel, Thomas ^b   Hinkelbein, Wolfgang ^b   Dinges, Stefan ^c   Budach, Volker ^a   Loening, Stefan A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Municipal Hospital of Lueneburg   (Germany)

Author keywords

External beam radiotherapy; High dose rate brachytherapy; Iridium 192; Prostate cancer

Indexed keywords

IRIDIUM 192; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONSERVATIVE TREATMENT; DYSURIA; FISTULA; HEMATURIA; HUMAN; INTERSTITIAL RADIATION; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RADIOISOTOPE THERAPY; RECTOURETHRAL FISTULA; TREATMENT FAILURE; URETHRA STRICTURE; URINARY FREQUENCY;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 0036555439     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00016-7     Document Type: Article

References (23)

1. Catalona WJ, Smith DS. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results. J Urol 1998;160:2428-34.
2. Zincke H, Bergstralh EJ, Blute ML, Myers RP, Barrett DM, Lieber MM, et al. Radical prostatectomy for clinically localized prostate cancer: Long-term results of 1,143 patients from a single institution. J Clin Oncol 1994;12:2254-63.
3. Fahlenkamp D, Müller W, Deger S, Loening SA. Laparoscopic pelvic lymphadenectomy patients with localized prostate cancer, experience in 217 patients. Eur Urol 1996;30(Suppl 2):87.
4. Deger S, Dinges S, Roigas J, Schnorr D, Türk I, Budach V, et al. High dose rate iridium 192 afterloading therapy in combination with external beam irradiation for localized prostate cancer. Technol Urol 1997;3:190-4.
5. Dinges S, Deger S, Koswig S, Boehmer D, Schnorr D, Wiegel T, et al. High dose rate interstitial with external beam irradiation for localized prostate cancer: Results of a prospective trial. Radiother Oncol 1998;48:197-202.
6. International Commission on Radiation Units and Measurements. ICRU Report No. 50. Prescribing, Recording, and Reporting Photon Beam Therapy. Bethesda: ICRU, 1993.
7. Rubin P, Constine LS, Fajardo LF, et al. Late effects consensus conference: RTOG/EORTC. Radiother Oncol 1995;35:5-7.
8. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;35:1035-41.
9. Radge H, Blasko CB, Grimm PD, Kenny GM, Sylvester J, Hoak DC, et al. Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-years follow-up. Semin Surg Oncol 1997;13:438-43.
10. Weyrich TP, Kandzari S, Jain PR. Iodine 125 seed implants for prostatic carcinoma. Urology 1993;41:122-6.
11. Kuban DA, El-Mahdi AM, Schellhammer P. I-125 interstitial implantation for prostate cancer, what have we learned 10 years after? Cancer 1989;63:2415-20.
12. Loening SA. Gold seed implantation in prostate brachytherapy. Semin Surg Oncol 1997;13:419-24.
13. Butler BE, Scardino PT, Teh BS, Uhl BM, Guerriero GW, Charlton EC, et al. The Baylor College of Medicine experience with gold seed implantation. Semin Surg Oncl 1997;13:406-18.
14. Hanks GE, Hanlon AL, Schultheiss TE, Freedman GM, Hunt M, Pinover WH, Movsas B. Conformal external beam treatment of prostate cancer. Urology 1907;50:87-92.
15. Perez CA, Hanks GE, Leibel SA, Zietman AL, Fuks Z, Lee RW. Localized carcinoma of the prostate: Review of management with external beam radiation therapy. Cancer 1993;72:3156.
16. Schellhammer PF, Jordan GH, El-Mahid AM. Pelvic complications after interstitial and external beam radiation of urologic and gynecologic malignancy. World J Surg 1986:10:259.
17. Kaye KW, Olson DJ, Payne JT. Detailed preliminary analysis of iodine 125 implantation for localized prostate cancer using percutaneous approach. J Urol 1995;153:1020.
18. Zeitlin J, Sherman J, Raboy A, Lederman G, Albert P. High dose combination radiotherapy for localized prostate cancer. J Urol 1998;160:91.
19. Marinelli D, Shanberg AM, Tansey LA, Sawyer DE, Syed N, Puthawala A. Follow-up prostate biopsy in patients with carcinoma of prostate treated by iridium 192 template irradiation plus supplemental external beam radiation. J Urol 1992;147:922.
20. Klein FA, Ali MM, Marks SE, Hackler RH. Bilateral pelvic lymphadenectomy, iridium 192 template and external beam therapy for localized prostatic carcinoma: Complications and results. South Med J 1988;81:27.
21. Kovacs G, Wirth B, Bertermann H. Prostate preservation by combined external beam and HDR brachytherapy at node negative prostate cancer patients: An intermediate analysis after 10 years experience. Int J Radiat Oncol Biol Phys 1996;36(Suppl 1):198.
22. Borghede G, Hedelin H. Radiotherapy of localised prostate cancer. Analysis of late treatment complications: A prospective study. Radiother Oncol 1997;43:139.
23. Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA. Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 2000:48:643-7.